Molina Healthcare, Inc. (NYSE:MOH – Get Free Report) Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the sale, the director now owns 18,025 shares in the company, valued at approximately $6,114,260.25. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Molina Healthcare Stock Performance
MOH traded up $17.76 during trading on Tuesday, hitting $350.73. The stock had a trading volume of 1,107,069 shares, compared to its average volume of 491,397. Molina Healthcare, Inc. has a one year low of $282.96 and a one year high of $423.92. The firm has a market cap of $20.55 billion, a price-to-earnings ratio of 19.03, a P/E/G ratio of 1.10 and a beta of 0.58. The company has a 50 day moving average price of $306.74 and a 200-day moving average price of $352.62. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.57 and a quick ratio of 1.57.
Molina Healthcare (NYSE:MOH – Get Free Report) last released its quarterly earnings results on Wednesday, July 24th. The company reported $5.86 EPS for the quarter, topping analysts’ consensus estimates of $5.73 by $0.13. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The business had revenue of $9.88 billion for the quarter, compared to analyst estimates of $9.75 billion. During the same period last year, the firm earned $5.65 earnings per share. Molina Healthcare’s revenue for the quarter was up 18.7% compared to the same quarter last year. As a group, research analysts predict that Molina Healthcare, Inc. will post 23.16 EPS for the current year.
Institutional Investors Weigh In On Molina Healthcare
Analyst Upgrades and Downgrades
A number of equities research analysts have recently issued reports on MOH shares. Cantor Fitzgerald reiterated an “overweight” rating and set a $406.00 price objective on shares of Molina Healthcare in a research note on Tuesday, July 23rd. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Molina Healthcare from $354.00 to $353.00 and set a “hold” rating for the company in a research report on Monday. Wells Fargo & Company decreased their price objective on shares of Molina Healthcare from $375.00 to $315.00 and set an “equal weight” rating for the company in a research report on Monday, July 22nd. TD Cowen dropped their price objective on Molina Healthcare from $412.00 to $351.00 and set a “buy” rating on the stock in a research note on Wednesday, July 24th. Finally, Stephens restated an “equal weight” rating and issued a $320.00 price objective on shares of Molina Healthcare in a research note on Thursday, July 25th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Molina Healthcare has an average rating of “Moderate Buy” and an average price target of $374.25.
Read Our Latest Stock Report on Molina Healthcare
About Molina Healthcare
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles
- Five stocks we like better than Molina Healthcare
- Where to Find Earnings Call Transcripts
- AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
- What is a Secondary Public Offering? What Investors Need to Know
- Harley-Davidson Stock Revs Up With Billion Dollar Buyback Program
- Are Penny Stocks a Good Fit for Your Portfolio?
- Cruise Line Stock Sinks Despite Beating EPS and Raised Guidance
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.